Annex 21 is sometimes viewed as a narrow regulatory annex, but its implications are much broader. It sits at the intersection ...
The number of approved advanced therapies may triple by 2030. The majority of health system survey respondents agreed (63%) ...
In the second part of his interview with Pharmaceutical Commerce, Roel van den Akker, Deals partner at PwC, discusses the ...
In today’s Pharma Pulse, Walgreens reshapes pharmacist roles, pharmacies expand injectable access, GoodRx and Eli Lilly ...
Anthony “TJ” Rizzo explains what makes an effective supply chain partnership, and how tech can be deployed alongside human ...
Richard Harrop shares how pharma can strike a balance between performance, sustainability, and resilience in packaging design ...
Seamus Keane discusses resilient supply chain design ahead of his panel at LogiPharma 2026.
Network “intelligence” depends on flexible modal strategies, diversified gateways, and pre-qualified alternative lanes, ...
Richard Harrop shares how pharma can strike a balance between performance, sustainability, and resilience in packaging design ...
Ahead of his presentation at LogiPharma 2026, Anthony “TJ” Rizzo discusses how automation and real-time monitoring can be ...
Laura Blair discusses what makes enrollment friction, and how the right balance of AI and human support can improve hub utilization and speed to therapy. The specialty pharmaceutical industry has ...
Laura Blair explains why streamlining the patient journey via and simpler tools help ensure adherence from the point of prescription. In this final installment her interview with Pharmaceutical ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results